Expert Advisory Committee on Xenograft Regulation

The Expert Advisory Committee (EAC) on Xenograft Regulation was formed to provide the Biologics and Genetic Therapies Directorate with timely advice on our medical, scientific, ethical and communication issues related to the regulation of xenografts. Collectively, the EAC members provide health professional and related expertise and advice pertaining to risk/benefit assessments conducted by others within Health Canada in order to assist the Biologics and Genetic Therapies Directorate with making appropriate risk management decisions. The decision-making responsibility remains with the Biologics and Genetic Therapies Directorate. Occasionally, the EAC members may also be requested to serve on appeal panels and to provide advice to the Directorate through other mechanisms. Committee members may also be consulted by other departments of Health Canada.

Record of Meeting

• Date: 2002-06-26
• Date: 2001-02-22
• Date: 2000-09-15
• Date: 2000-04-26
• Date: 2000-02-17
• Date: 2000-01-12
• Date: 1999-11-02
• Date: 1999-09-01